Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.1 CAD | +1.94% | -4.55% | -22.22% |
17/04 | NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update | MT |
17/04 | NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.22% | 11Cr | |
+67.53% | 6.39TCr | |
-0.77% | 4.18TCr | |
+42.61% | 4.05TCr | |
-10.02% | 2.72TCr | |
+13.30% | 2.65TCr | |
-22.79% | 1.87TCr | |
+4.70% | 1.27TCr | |
+24.10% | 1.21TCr | |
+27.41% | 1.21TCr |
- Stock Market
- Equities
- NGEN Stock
- News NervGen Pharma Corp.
- NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update